Skip to content
Trial Eligibility
Menu

Amygdala Neurofeedback for Depression - Large Scale Clinical Trial

NCT05703256

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as a stand-alone intervention for major depressive disorder

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Major Depressive Disorder

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 55 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Kymberly Young
Last updated on ClinicalTrials.gov
March 4, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • University of Pittsburgh · Pittsburgh, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.